SHW Drops After Q3 Print as Analysts Trim Targets
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Sherwin-Williams reported Q3 results on October 27 and promptly gave back 3% over the following session, reversing the call-buying optimism that had built ahead of the print and leaving the stock down roughly 3% on the week at $326.01.
The options picture shifted sharply once results landed. The put/call ratio climbed to 0.89, well above its 20-day average of 0.77, and sits about 1.5 standard deviations above that mean. That reverses the bullish positioning from earlier in the week, when calls had dominated ahead of the earnings release. The 52-week PCR range runs from 0.51 to 1.20, so the current reading is in the upper half but not extreme. Short interest, at 2.7% of free float, is not the story here. It actually fell roughly 9% over the week to around 6.66 million shares, meaning bears were covering ahead of and around the print rather than pressing new positions. Borrow remains trivially cheap at 0.36%, and availability is completely unconstrained at over 8,000%, so the lending market places no friction on anyone who wants to short.
The analyst response after the Q3 release was broad and consistent: targets came down, ratings held. DA Davidson lowered its target to $390 from $400 while keeping its Buy. Guggenheim did the same, cutting to $375 from $400 and maintaining Buy. Barclays trimmed to $329 from $348 on its Equal-Weight. The consensus mean price target now sits at $379, implying roughly 16% potential return from current levels. That gap between where the stock trades and where analysts think it should be captures the debate. Bulls, as laid out in the Benzinga case, point to 4,800 company-owned stores, 1.5x-to-2x market growth capability, $3.4 billion in free cash flow and 2027 EPS seen around $14 with more than 10% growth. Bears counter that weak Paint Stores and Consumer demand, raw material inflation, a stalled existing home sales market, and FX pressure in Brazil and Asia can compress that path. The EV/EBITDA multiple has contracted about 0.45 turns over the past month to 17.75, reflecting some of that pressure in the valuation. The PE at 24.6x has shed roughly 0.6 turns over the same period.
One alt-data point worth noting: retail attention on SHW spiked sharply around the earnings date. Wikipedia page views and ORTEX stock-page traffic both rose, producing a combined attention z-score of 2.4 against the prior 90 days, as tracked by the Wikimedia Foundation and ORTEX data. That kind of attention burst often fades quickly once a catalyst passes. Separately, the company's SEC EDGAR filings show it spent $1.26 billion on buybacks in Q2 2026, up 143% on the same quarter a year earlier, repurchasing 4 million shares, up 176% year-on-year. Neither of these datasets has been measured to lead revenue, so they are context rather than signal for the next print.
The peer comparison cuts against SHW this week. PPG gained 4.4% over the same period, AXTA added 2.3%, and ECL rose 1.1%. RPM fell 1.7%, so SHW's 3% drop was not a sector-wide move. The stock underperformed its closest coatings peers on both the day and the week. That divergence matters because the pre-earnings preview published here on October 24 noted SHW already trailing peers into the print. The earnings reaction extended rather than corrected that gap.
The next scheduled print is January 26, 2027, giving the market 90 days to watch whether existing home sales recover and whether raw material costs ease enough to restore confidence in the 2027 EPS trajectory.
Stocks in this article
See the live data behind this article on ORTEX.
Open SHW on ORTEX →How this article was generated
- Generated
- 28 Oct 2026, 18:52
- Data as of
- 28 Oct 2026, 18:52
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.